IP Library Granted Patent US 11,471,559
Granted Patent B2
US 11,471,559 · App. 15/818,147 · Granted Oct 18, 2022

Bioenergetic bone

Inventors: Timothy Ganey (Tampa, FL); Wendy W. Weston (Miami, FL); Miguel Quevedo (Miami, FL); Stuart Oglesby (Miami, FL); Tracy Scott Anderson (Atlanta, GA)
Assignee: Vivex Biologics Group, Inc.
A61L27/3608A61K35/28A61K35/32A61L27/3604A61L27/365A61L27/3687A61L27/3691A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,471,559
App. No.
15/818,147
Granted
Oct 18, 2022
Kind
B2
Abstract

A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.

Claims (7)

1. A biological composition comprising:

a mixture of mechanically selected biologic material derived from bone marrow having non-whole cellular components and non-cellular fractions consisting of exosomes, vesicular components, organelle fragments and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components wherein the mixture excludes and is isolated from whole cells to yield non-cellular fractions or non-cellular components or combinations in a size ranging from 20 to 100 nm in diameter to create the mixture; freeze-dried bone particles, prior to freeze-drying the bone particles are suspended in saline and sealed in a container, the bone particles are then exposed to a mechanical, atmospheric or membrane charge adjustment by creating a vacuum within the sealed container by exposing the bone particles suspended in the saline to a shock wave of a compressed wave of high amplitude through the container to create enhanced bone particles that are bone inductive prior to the freeze-drying process, the freeze-drying is run for greater than 24 hours to dry the enhanced bone particles without adversely affecting the structural or physical properties of the enhanced bone particles, the freeze-dried enhanced bone particles being added to the mixture derived from bone marrow, wherein the freeze-dried enhanced bone particles include a mixture of enhanced cortical bone particles and enhanced cancellous bone particles ground and sieved to a size of 100-300 pm; a protectant or cryoprotectant of polyampholyte added to the mixture, the protectant or cryoprotectant treats the mixture of mechanically selected biologic material creating a physical or electrical or chemical gradient or combination thereof for osteoinductive bone tissue regeneration, and wherein the mixture of mechanically selected biologic material treated with the protectant or cryoprotectant of polyampholyte along with the freeze-dried enhanced bone particles in the mixture forms the biological composition which is compatible with biologic function and can be implanted directly into the patient or a graft recipient and wherein the mixture of mechanically selected biologic material derived from bone marrow is in an unfrozen non-freeze-dried state and treated in the protectant or cryoprotectant of polyampholyte in the unfrozen, non-freeze-dried state prior to preservation or cryopreservation or freeze drying to form a preserved unfrozen composition or a frozen cryopreserved composition or a freeze-dried composition including the protectant or cryoprotectant of polyampholyte and freeze-dried enhanced bone particles.

2. The biological composition of claim 1 wherein active and inactive components of biological activity can be extants of the human metabolome.

3. The biological composition of claim 1 wherein the composition is maintained at ambient temperature prior to freeze drying.

4. The biological composition of claim 1 wherein the composition does not require cryopreservation to afford regenerative potential.

5. A biological composition comprising:

a mixture of mechanically selected biologic material derived from bone marrow consisting of non-whole cellular components and non-cellular fractions including exosomes, vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components wherein the mixture excludes and is isolated from whole cells to yield non-cellular fractions or non-cellular components or combinations to create the mixture; bone particles, the bone particles are suspended in saline and sealed in a container, the bone particles are then exposed to a mechanical, atmospheric or membrane charge adjustment by creating a vacuum within the sealed container by exposing the bone particles suspended in the saline to a shock wave of a compressed wave of high amplitude through the container to create enhanced bone particles that are bone inductive, the enhanced bone particles being added to the mixture derived from bone marrow, wherein the enhanced bone particles include a mixture of enhanced cortical bone particles and enhanced cancellous bone particles; a protectant or cryoprotectant of polyampholyte added to the mixture with the enhanced bone particles, the protectant or cryoprotectant treats the mixture of mechanically selected biologic material and the enhanced bone particles creating a physical or electrical or chemical gradient or combination thereof for tissue regeneration; and wherein the mixture intermixed with the enhanced bone particles and the protectant or cryoprotectant of polyampholyte forms the biological composition which is compatible with biologic function, wherein the mixture of mechanically selected biologic material derived from bone marrow and the enhanced bone particles are in an unfrozen non-freeze-dried state and treated in the protectant or cryoprotectant of polyampholyte in the unfrozen, non-freeze-dried state prior to freeze drying, thereafter freeze-drying to form a freeze-dried composition including the protectant or cryoprotectant of polyampholyte, the freeze-dried composition can be implanted directly into the patient or a graft recipient, wherein the freeze-drying is run for greater than 24 hours to dry the enhanced bone particles without adversely affecting the structural or physical properties of the enhanced bone particles.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2022
From: BANKUNITED, N.A.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 061333/0853 →
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2019
From: VIVEX BIOLOGICS GROUP, INC.
To: BANKUNITED, N.A.
Reel/Frame 051260/0064 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOMEDICAL, INC.
To: VIVEX BIOLOGICS, INC.
Reel/Frame 050079/0179 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOLOGICS, INC.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 050079/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2017
From: GANEY, TIMOTHY; WESTON, WENDY W.; QUEVEDO, MIGUEL; OGLESBY, STUART; ANDERSON, TRACY SCOTT
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 044188/0416 →